Related Experiment Video
Updated: Jul 18, 2026

Dynamic Contrast Enhanced Magnetic Resonance Imaging of an Orthotopic Pancreatic Cancer Mouse Model
Published on: April 18, 2015
Bayesian methods for pharmacokinetic models in dynamic contrast-enhanced magnetic resonance imaging
Volker J Schmid1, Brandon Whitcher, Anwar R Padhani
1Institute of Biomedical Engineering, Imperial College, London SW7 2AZ, UK.
This study introduces a novel method for dynamic contrast-enhanced MRI kinetic parameter estimation using adaptive Gaussian Markov random fields. This approach enhances tumor analysis by reducing variability and improving consistency in breast cancer imaging.
Area of Science:
- Medical Imaging
- Biophysics
- Computational Biology
Background:
- Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) is crucial for assessing tissue characteristics.
- Estimating kinetic parameters in DCE-MRI is vital for tumor analysis but faces challenges with variability.
- Existing methods may struggle with preserving tissue boundary details.
Purpose of the Study:
- To propose a new method for estimating kinetic parameters in DCE-MRI.
- To leverage adaptive Gaussian Markov random fields for improved parameter estimation.
- To enhance the analysis of tumor regions and tissue heterogeneity.
Main Methods:
- Developed a novel method for DCE-MRI kinetic parameter estimation.
- Utilized adaptive Gaussian Markov random fields incorporating neighborhood voxel information.
- Employed Bayesian estimation and compared standard errors with likelihood-based nonlinear regression.
Main Results:
- The proposed method reduces variability in local tumor regions.
- Sharp transitions between heterogeneous tissue boundaries are preserved.
- Bayesian analysis with adaptive Gaussian Markov random fields demonstrated improved convergence and consistency.
Conclusions:
- The integration of Bayesian analysis and adaptive Gaussian Markov random fields offers enhanced DCE-MRI kinetic parameter estimation.
- This method provides more consistent morphological and functional statistics for breast tumor analysis.
- The approach effectively balances noise reduction with the preservation of critical tissue boundary information.
More Related Videos
06:31Quantitative [18F]-Naf-PET-MRI Analysis for the Evaluation of Dynamic Bone Turnover in a Patient with Facetogenic Low Back Pain
Published on: August 8, 2019
08:59Use of a Multi-compartment Dynamic Single Enzyme Phantom for Studies of Hyperpolarized Magnetic Resonance Agents
Published on: April 15, 2016
Related Concept Videos
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model
Pharmacokinetic–Pharmacodynamic Relationship: Model Components
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...